Business

U.S. FDA Flags Quality, Procedural Lapses At Biocon Biologics’ Facilities

[ad_1]

The U.S. FDA issued Form 483s with 11 observations each for the two sites in Bengaluru and six for the Malaysia site.

[ad_2]

Source link

What is your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Comments are closed.

More in:Business